Adenocarcinoma Of The Colon clinical trials

Explore recruiting adenocarcinoma of the colon clinical trials.

Recruiting adenocarcinoma of the colon studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adenocarcinoma Of The Colon trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to learn more about how safe BAY 3771249 is and how well it works in people with advanced or metastatic colorectal cancer that has a KRAS G12D mutation

Finland, Spain, Sweden, Italy, Denmark, Netherlands +1 more

Human Pharmacology (Phase I)- Other EU CTIS Study details

Neoadjuvant immune checkpoint inhibition and novel IO combinations in early-stage colon cancer - the NICHE trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, Randomized, Open-Label Clinical Study of Napabucasin in Combination with FOLFIRI and Best Supportive Care (BSC) Versus Napabucasin plus BSC in Adult Patients with Previously Treated Metastatic Colorectal Cancer (CRC)

Spain, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of the use of neoadjuvant with/without hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced colon cancer: A phase III multi-arm, randomized and controlled clinical trial (FOXHIPECT4)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

TRIFLUOX-DP: Safety of Trifluridine/tipiracil as replacement of fluoropyrimidines (5-fluorouracil and capecitabine) based chemotherapy as first line metastatic colorectal or gastroesophageal cancer regimens in patients with dihydropyrimidine dehydrogenase deficiency: a phase II trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Adenocarcinoma Of The Colon trials by city

Adenocarcinoma Of The Colon in Toronto Adenocarcinoma Of The Colon in Vancouver Adenocarcinoma Of The Colon in Montreal Adenocarcinoma Of The Colon in Calgary Adenocarcinoma Of The Colon in Edmonton Adenocarcinoma Of The Colon in Ottawa Adenocarcinoma Of The Colon in Winnipeg Adenocarcinoma Of The Colon in Quebec City Adenocarcinoma Of The Colon in Hamilton Adenocarcinoma Of The Colon in Kitchener Adenocarcinoma Of The Colon in London Adenocarcinoma Of The Colon in Halifax Adenocarcinoma Of The Colon in New York Adenocarcinoma Of The Colon in Los Angeles Adenocarcinoma Of The Colon in Chicago Adenocarcinoma Of The Colon in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease